# National Evaluation of PI-based 2nd Line Efficacy in Cambodia

> **NCT01801618** · — · COMPLETED · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 15001351 (actual)

## Conditions studied

- HIV

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01801618
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-07
- **Final completion:** 2014-12
- **Target enrollment:** 15001351 (ACTUAL)
- **Last updated:** 2016-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01801618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01801618, "National Evaluation of PI-based 2nd Line Efficacy in Cambodia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01801618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*